Low molecular weight heparin self-injection training: Assessment of feasibility, tolerance and economic analysis in emergency departments

European Journal of Emergency Medicine

Volumn 13, Issue 5, 2006, Pages 264-269

  Gall, Catherine Le ^a,c   Jacques, Eric ^a   Medjebeur, Claude ^b   Darques, Loic ^a   Briand, François ^a   Haddad, Joseph ^a   Bleichner, Gérard ^a  

^a GENERAL HOSPITAL   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

^c CENTRE HOSPITALIER VICTOR DUPOUY   (France)

Author keywords

Emergency department; Low molecular weight heparin; Self injection training; Thrombo embolic prophylaxis

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG TOLERABILITY; ECONOMIC ASPECT; EMERGENCY WARD; ERYTHEMA; FEASIBILITY STUDY; FEMALE; HEMATOMA; HEPARINIZATION; HUMAN; INJECTION SITE BLEEDING; LEG; MAJOR CLINICAL STUDY; MALE; NURSE; ORTHOPEDIC SURGERY; PAIN; PATIENT COMPLIANCE; PATIENT EDUCATION; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SELF INJECTION; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ADULT; ANTICOAGULANTS; ATTITUDE TO HEALTH; COST SAVINGS; EMERGENCY SERVICE, HOSPITAL; FEASIBILITY STUDIES; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; PROSPECTIVE STUDIES; QUESTIONNAIRES; SELF ADMINISTRATION;

EID: 33748754090     PISSN: 09699546     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063110-200610000-00004     Document Type: Article

References (9)

1. Hjelmstedt A, Bergvall U. Incidence of thrombosis in patients with thrombosis with tibial fractures: a phlebographic study. Acta Chir Scand 1968;134:209-218.
2. Abelseth G, Buckley RE, Pineo GE, Hull R, Rose MS. Incidence of deep vein thrombosis in patients with fractures of the lower extremity distal to the hip. J Orthop Trauma 1996; 10:230-235.
3. Prophylaxy of thrombo-embolic disease in post-surgery. Guideline of Public Assistance Hospital of Paris. (Prophylaxie des thromboses veineuses post-opératoires. Recommandations de l'Assistance Publique des Hôpitaux de Paris). Février 1995; extrait de sang et thrombose.
4. Geerts W, Heit J, Clagett P, Pineo G, Colwell C, Anerson F, Wheeler B. prevention of venous thromboembolism. Chest 2001; 119:132S-175S.
5. Assessment of prescription of low molecular weight heparin in prevention of thrombo-embolic disease. French National Health Security Center. (Rapport d'étude des prescriptions des héparines de bas poids moléculaires (HBPM pour la prévention du risque veineux thrombo-embolique). Régime AMPI. Caisse nationale de l'assurance maladie des professions indépendantes. Novembre 1999.
6. Review: low molecular weight heparin (Le point sur les héparines de bas poids moléculaire). AFSSAPS, Avril 2002. http://agmed.sante.gouv. fr.
7. Koopman MM, Prandoni P, Piovella F, Ockelford PA, Brandjes DP, Van der Meer J, Gallus AS, Simonneau G, Chesterman CH, Prins MH, et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular weight heparin administered at home. The TASMAN Study Group. N Engl J Med 1996; 334:682-687.
8. Vinson DR, Berman DA. Outpatient treatment of deep venous thrombosis: a clinical care pathway managed by the emergency department. Ann Emerg Med 2001; 37:251-258.
9. Levine M, Willan A, et al. Economic evaluation of out-patient treatment with low-molecular-weight-heparin for proximal vein thrombosis. Arch Intern Med 2000; 160:2926-2932.